Instrument Inactif

Autres langues OSI Pharmaceuticals, Inc.

Actions

US6710401034

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

2010

OSI PHARM : a reçu une offre de rachat du japonais Astellas

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

OSI PHARM : Astellas Completes Acquisition of OSI Pharmaceuticals	09/06/10
OSI PHARM : Astellas Announces Successful Completion of Tender Offer for Shares of OSI	08/06/10
OSI PHARM : OSI Pharmaceuticals Announces Occurrence of a Fundamental Change for Convertible Notes	04/06/10
OSI PHARM : Astellas Announces Successful Completion of Initial Tender Offer for Shares of OSI and Announces Subsequent Offer Period	03/06/10
OSI PHARM : Expiration Date of OSI Offer Extended to June 2, 2010	17/05/10
OSI PHARM : Astellas Pharma Inc. to Acquire OSI Pharmaceuticals, Inc.	17/05/10
OSI PHARM : Expiration Date of OSI Offer Extended to May 17, 2010	23/04/10
OSI PHARM : Expiration Date of OSI Offer Extended to April 23, 2010	31/03/10
OSI PHARM : Astellas Signs Confidentiality Agreement With OSI	29/03/10
OSI PHARM : Astellas Announces Changes to Director Nominees for Election to OSI Pharmaceuticals' Board of Directors	19/03/10
OSI PHARM : Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals' 2010 Annual Stockholders Meeting	16/03/10
OSI PHARM : Astellas Responds to OSI Pharmaceuticals' Rejection	15/03/10
OSI PHARM : Astellas Pharma Inc. Commences Tender Offer to Acquire All Outstanding Shares of OSI Pharmaceuticals for $52 per Share in Cash	02/03/10
OSI PHARM : Astellas Pharma Inc. Offers to Acquire OSI Pharmaceuticals for $52.00 Per Share in Cash	01/03/10
OSI PHARMACEUTICAL : Seven Summits Research Releases Comments on MRK, PNC, SNDK, TYC, and OSIP	03/02/09
Osi Pharmaceuticals : OSI Pharmaceuticals to Present at the UBS Global Life Sciences Conference on Wednesday, September 26, 2007	19/09/07
Osi Pharmaceuticals : OSI Pharmaceuticals Announces Patent Term Extension for Tarceva(R) (erlotinib)	18/09/07
Osi Pharmaceuticals : OSI Pharmaceuticals Summarizes Data Presented on Tarceva(R) (erlotinib) at the 12th World Congress on Lung Cancer Meeting	07/09/07
Osi Pharmaceuticals : OSI Pharmaceuticals Announces Positive Results from a Metformin Drug Interaction Study with Its DP-IV Inhibitor, PSN9301	06/09/07
Osi Pharmaceuticals : OSI Pharmaceuticals Announces Second Quarter 2007 Financial Results	30/07/07

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues OSI Pharmaceuticals, Inc.

Actions

US6710401034

Autres langues

Filtres